Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (359)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

SearchSort evidence

All359 Core251 Supporting111 Background0

Showing 313-324 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2024CrossrefDirectly related0 citations

Glucagon-like Peptide 1 Receptor Agonists and Obesity Associated with Eating Disorders

Riccardo Dalle Grave

Nov 18, 2024IJEDO

2024OpenAlexDirectly related44 citations

Incretin-based therapies for the treatment of obesity-related diseases

Irene Caruso; Angelo Cignarelli; Gian Pio Sorice; Sebastio Perrini; Francesco Giorgino

Nov 6, 2024npj Metabolic Health and Disease

2024OpenAlexDirectly related39 citations

Use of SGLT2 Inhibitors vs GLP-1 RAs and Anemia in Patients With Diabetes and CKD

Jia-Chian Hu; Shih‐Chieh Shao; Daniel Hsiang‐Te Tsai; Albert Tzu-Ming Chuang; Kuan‐Hung Liu; Edward Chia‐Cheng Lai

Mar 4, 2024JAMA Network Open

2024CrossrefDirectly related26 citations

Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

Ronald M. Goldenberg; Jeremy D. Gilbert; Priya Manjoo; Sue D. Pedersen; Vincent C. Woo; Julie A. Lovshin

Mar 1, 2024Obesity Reviews

2024PubMedDirectly related

Oral Adverse Effects of Semaglutide Therapy: A Narrative Review.

Al-Zawawi AS

Jan 1, 2024Journal of International Society of Preventive & Community Dentistry

2024CrossrefDirectly related0 citations

Reprogramming of GLP-1 Response at Prediabetes for the Prevention of Type 2 Diabetes: The Role of Albumin and GLP-1 Receptor Agonists

Amr Ahmed

Jan 1, 2024Cell & Cellular Life Sciences Journal

2023OpenAlexDirectly related124 citations

The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)

Roger S. McIntyre; Rodrigo B. Mansur; Joshua D. Rosenblat; Angela T.H. Kwan

Dec 13, 2023Expert Opinion on Drug Safety

2023OpenAlexSupporting evidence3,061 citations

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff; Kirstine Brown‐Frandsen; Helen M. Colhoun; John Deanfield; Scott S. Emerson; Sille Esbjerg; Søren Hardt‐Lindberg; G. Kees Hovingh; Steven E. Kahn; Robert F. Kushner; Ildiko Lingvay; Tuğçe Kalaycı Oral; Marie Mide Michelsen; Jorge Plutzky; Christoffer W. Tornøe; Donna H. Ryan

Nov 11, 2023New England Journal of Medicine

2023OpenAlexDirectly related246 citations

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach

Jingyue Wang; Quanwei Wang; Xinyu Yang; Wei Yang; Dong-Rui Li; Jingyu Jin; Hui-Cong Zhang; Xianfeng Zhang

Feb 1, 2023Frontiers in Endocrinology

2022OpenAlexDirectly related51 citations

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations

Dan Xu; Ankith Nair; Charlie Sigston; Chau Ho; Jia Li; Daya Yang; Xinxue Liao; Wei Chen; Ming Kuang; Yanbing Li; Christopher M. Reid; Haipeng Xiao

Nov 16, 2022Cardiovascular Therapeutics

2022CrossrefDirectly related2 citations

504-P: Success of Aligned Clinician–Patient Education Improves Clinicians’ Ability to Use GLP-1 RAs in Practice and Patients’ Understanding of GLP-1 RAs

AMY LARKIN; ANNE LE

Jun 1, 2022Diabetes

2022OpenAlexSupporting evidence664 citations

Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

Jennifer A. Ligibel; Kari Bohlke; Anne M. May; Steven K. Clinton; Wendy Demark‐Wahnefried; Susan C. Gilchrist; Melinda L. Irwin; Michele Late; Sami Mansfield; Timothy Marshall; Jeffrey A. Meyerhardt; Cynthia A. Thomson; William A. Wood; Catherine M. Alfano

May 16, 2022Journal of Clinical Oncology

Page 27 of 30Showing 313-324 of total 359 results.

1...262728...30

GLP-1 receptor agonists for obesity treatment — Research Evidence and Topic... | Kritoma